CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL, D. SEIDEL, K. ALBUS, J. N. DE ALMEDIA, G. GARCIA-EFFRON, N. GILROY, C. LASS-FLORL, L. OSTROSKY-ZEICHNER, L. PAGANO, T. PAPP, R. RAUTEMAA-RICHARDSON, J. SALMANTON-GARCIA, A. SPEC, J. STEINMANN, S. ARIKAN-AKDAGLI, D. E. ARENZ, R. SPRUTE, L. DURAN-GRAEFF, Tomáš FREIBERGER, C. GIRMENIA, M. HARRIS, S. S. KANJ, M. ROUDBARY, O. LORTHOLARY, J. MELETIADIS, E. SEGAL, F. F. TUON, N. WIEDERHOLD, T. BICANIC, J. CHANDER, Y. C. CHEN, P. R. HSUEH, M. IP, P. MUNOZ, I. SPRIET, E. TEMFACK, L. THOMPSON, A. M. TORTORANO, A. VELEGRAKI and N. P. GOVENDER. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infectious Diseases. Oxford: Elsevier SCI LTD, 2021, vol. 21, No 12, p. "E375"-"E386", 12 pp. ISSN 1473-3099. Available from: https://dx.doi.org/10.1016/S1473-3099(21)00203-6.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
Authors CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL, D. SEIDEL, K. ALBUS, J. N. DE ALMEDIA, G. GARCIA-EFFRON, N. GILROY, C. LASS-FLORL, L. OSTROSKY-ZEICHNER, L. PAGANO, T. PAPP, R. RAUTEMAA-RICHARDSON, J. SALMANTON-GARCIA, A. SPEC, J. STEINMANN, S. ARIKAN-AKDAGLI, D. E. ARENZ, R. SPRUTE, L. DURAN-GRAEFF, Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), C. GIRMENIA, M. HARRIS, S. S. KANJ, M. ROUDBARY, O. LORTHOLARY, J. MELETIADIS, E. SEGAL, F. F. TUON, N. WIEDERHOLD, T. BICANIC, J. CHANDER, Y. C. CHEN, P. R. HSUEH, M. IP, P. MUNOZ, I. SPRIET, E. TEMFACK, L. THOMPSON, A. M. TORTORANO, A. VELEGRAKI and N. P. GOVENDER.
Edition Lancet Infectious Diseases, Oxford, Elsevier SCI LTD, 2021, 1473-3099.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30303 Infectious Diseases
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 71.421
RIV identification code RIV/00216224:14110/21:00123979
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/S1473-3099(21)00203-6
UT WoS 000723373700002
Keywords in English rare yeast infections; diagnosis; management
Tags 14110114, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 21/4/2022 10:13.
Abstract
Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients who are immunocompromised or seriously ill. The major pathogens include those of the genera Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon (ie, basidiomycetes) and Kodamaea, Malassezia, Pseudozyma (ie, now Moesziomyces or Dirkmeia), Rhodotorula, Saccharomyces, and Sporobolomyces (ie, ascomycetes). A considered approach to the complex, multidisciplinary management of infections that are caused by these pathogens is essential to optimising patient outcomes; however, management guidelines are either region-specific or require updating. In alignment with the One World-One Guideline initiative to incorporate regional differences, experts from diverse geographical regions analysed publications describing the epidemiology and management of the previously mentioned rare yeasts. This guideline summarises the consensus recommendations with regards to the diagnostic and therapeutic options for patients with these rare yeast infections, with the intent of providing practical assistance in clinical decision making. Because there is less clinical experience of patients with rare yeast infections and studies on these patients were not randomised, nor were groups compared, most recommendations are not robust in their validation but represent insights by use of expert opinions and in-vitro susceptibility results. In this Review, we report the key features of the epidemiology, diagnosis, antifungal susceptibility, and treatment outcomes of patients with Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon spp infections.
PrintDisplayed: 24/7/2024 23:24